The circulatory effects of catecholamines and ouabain in glucocorticoid-deficient animals.
D015065:17-Hydroxycorticosteroids; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001810:Blood Volume / Q000187:drug effects*; D003677:Deficiency Diseases / Q000139:chemically induced; D003632:Dichlorodiphenyldichloroethane; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006632:Histamine / Q000097:blood; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium; D009638:Norepinephrine / Q000494:pharmacology*; D010912:Pituitary-Adrenal Function Tests; D010949:Plasma / Q000187:drug effects*; D010953:Plasma Volume / Q000187:drug effects; D011188:Potassium / Q000097:blood; D011239:Prednisolone / Q000494:pharmacology; D012964:Sodium / Q000097:blood
D015065:17-Hydroxycorticosteroids; D006632:Histamine; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D011239:Prednisolone; D011188:Potassium; D003632:Dichlorodiphenyldichloroethane; D009638:Norepinephrine; D004837:Epinephrine